Advertisement Press Releases Archive - Page 175 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Changes in Supervisory Board at DASGIP AG

    Prof. Dr. Wiltrud Treffenfeldt, Global Director for Bioprocess R&D at Dow AgroSciences in Indianapolis, USA was elected to the supervisory board at DASGIP AG. She replaces Dr. Helmut Herz who resigned the board effective from May 20th 2011 after 5 years of membership. Both the Chairman Dr. Jürgen Kieschoweit as well as the long-standing member Rolf Geisen have been reelected.

  • Ready to Use: DASGIP and Mobius CellReady 3L Bioreactor

    DASGIP strengthens its market position by combining disposable benchtop bioreactors with the DASGIP technology. Thanks to the unique modularity of the DASGIP Parallel Bioreactor System the Mobius CellReady 3L bioreactor can be integrated seamlessly into DASGIP's control system. In this manner, DASGIP combines the familiar powerful process control with the advantages of disposable technology. The CellReady bioreactor is a single-use stirred tank bioreactor for cell culture process development. The disposable bioreactor eliminates the need to clean and autoclave, thus it accelerates preparation and post-processing time.

  • DASGIP Integrates Aber Futura Biomass Sensors

    DASGIP expand the 3rd party integration program and includes Aber Futura biomass sensors. This integration enables online monitoring of the viable cell concentration during the controlled cultivation in DASGIP Parallel Bioreactor systems. With Aber biomass sensors DASGIP integrates a further analytical tool for the advanced and efficient cultivation of bacteria, yeast and animal cells.

  • What Chambers & Partners say about Carpmaels & Ransford

    This London-based firm offers a full service to clients such as Johnson & Johnson, Micron Technology and Nissan. It is particularly well known for its patent expertise in the life sciences field, defending Novartis' patents for meningitis vaccines and Gilvec, a treatment for chronic myelogenous leukaemia. "Carpmaels & Ransford is very adaptable and always on the ball, providing commercial, strategic advice and acting as an excellent sounding board for new ideas," say sources.

  • New Tool for Routines Polymer Analysis: Multi-Shot EGA/PY-3030D/S Pyrolyzer

    Shimadzu, one of the worldwide leading manufacturers in analytical instrumentation and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu’s GCMS-QP2010 quadrupole series and Frontier Lab’s new Multi-Shot EGA/PY-3030D(S) vertical micro furnace pyrolyzer. Both companies have teamed up in Pyrolysis-GCMS for years.